腺病毒肺炎的抗病毒治疗

中国小儿急救医学 Pub Date : 2019-12-20 DOI:10.3760/CMA.J.ISSN.1673-4912.2019.12.001

J. Ying, G. Yan

{"title":"腺病毒肺炎的抗病毒治疗","authors":"J. Ying, G. Yan","doi":"10.3760/CMA.J.ISSN.1673-4912.2019.12.001","DOIUrl":null,"url":null,"abstract":"Adenovirus pneumonia is a common type of pneumonia in immunocompetent and immunocompromised patients, and its prognosis is poor.Antiviral therapy includs ganciclovir, valganciclovir, cidofovir, brincidofovir, ribavirin and so on.Among them, cidofovir and brincidofovir have obvious antiviral activity against adenovirus in vitro and in vivo, but further RCT results are still needed.Therefore, antiviral therapy of adenovirus pneumonia still needs further study. \n \n \nKey words: \nAdenovirus; Ganciclovir; Cidofovir; Ribavirin","PeriodicalId":68901,"journal":{"name":"中国小儿急救医学","volume":"26 1","pages":"881-884"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiviral therapy of adenovirus pneumonia\",\"authors\":\"J. Ying, G. Yan\",\"doi\":\"10.3760/CMA.J.ISSN.1673-4912.2019.12.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Adenovirus pneumonia is a common type of pneumonia in immunocompetent and immunocompromised patients, and its prognosis is poor.Antiviral therapy includs ganciclovir, valganciclovir, cidofovir, brincidofovir, ribavirin and so on.Among them, cidofovir and brincidofovir have obvious antiviral activity against adenovirus in vitro and in vivo, but further RCT results are still needed.Therefore, antiviral therapy of adenovirus pneumonia still needs further study. \\n \\n \\nKey words: \\nAdenovirus; Ganciclovir; Cidofovir; Ribavirin\",\"PeriodicalId\":68901,\"journal\":{\"name\":\"中国小儿急救医学\",\"volume\":\"26 1\",\"pages\":\"881-884\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国小儿急救医学\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1673-4912.2019.12.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国小儿急救医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-4912.2019.12.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

腺病毒性肺炎是免疫功能低下和免疫功能低下患者常见的肺炎类型，其预后较差。抗病毒治疗包括更昔洛韦、缬更昔洛韦、西多福韦、布林西多福韦、利巴韦林等。因此，腺病毒肺炎的抗病毒治疗仍需进一步研究。关键词：腺病毒；甘西洛韦；西多福韦；利巴韦林

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Antiviral therapy of adenovirus pneumonia

Adenovirus pneumonia is a common type of pneumonia in immunocompetent and immunocompromised patients, and its prognosis is poor.Antiviral therapy includs ganciclovir, valganciclovir, cidofovir, brincidofovir, ribavirin and so on.Among them, cidofovir and brincidofovir have obvious antiviral activity against adenovirus in vitro and in vivo, but further RCT results are still needed.Therefore, antiviral therapy of adenovirus pneumonia still needs further study. Key words: Adenovirus; Ganciclovir; Cidofovir; Ribavirin

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

中国小儿急救医学

自引率

0.00%

发文量

6226

期刊介绍： Chinese Journal of Neurology was established in 1955, the predecessor of which is Chinese Journal of Neurology and Psychiatry. Chinese Journal of Neurology and Psychiatry has been indexed by MEDLINE until 1996, when it was divided into two journals, Chinese Journal of Neurology, and Chinese Journal of Psychiatry. Chinese Journal of Neurology is now indexed by EM, SCOPUS, AJ, WPRIM, CNKI, Wanfang Data, CSCD, etc. The impact factor of the journal is 2.755 in 2017, ranking the first among all neurological and psychological journals in China and among all the 142 medical journals published by the Chinese Medical Association. The journal is available both in print and online.